Recommended Topic Related To:

NeoProfen

"The U.S. Food and Drug Administration today approved the MemoryShape Breast Implant to increase breast size (augmentation) for use in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. The MemoryShape B"...

NeoProfen

PATIENT INFORMATION

General

Patients' caregivers should be informed that the effects of ibuprofen on infants' neurodevelopmental outcome, growth and disease process with prematurity have not been assessed in long-term studies.

Infection

NeoProfen may alter signs of infection. Patients' caregivers should be informed that the infant will be carefully monitored for any signs of infection.

Platelet Aggregation

Patients' caregivers should be informed that like other NSAIDS, NeoProfen can inhibit clot formation therefore their infant will be monitored for any signs of bleeding.

Bilirubin Displacement

Patients' caregivers should be informed that the infants' blood will be tested for increased levels of total bilirubin.

Administration

Patients' caregivers should be informed that the infants' skin and tissues will be monitored as leakage from administration may be irritating to tissue.

Last reviewed on RxList: 12/12/2013
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.